Through its publications, INSS provides rigorous, forward‑looking research and analysis on critical national security issues that support the joint warfighter and inform Department of War decision‑makers.
Feb. 17, 2026
The Recent Rash of Biotechnology Risks: A Call to Fortify Force Capability
The tools of modern biology such as state-of-the-art gene editing, modular DNA assembly, cell-free systems, benchtop automation, and AI-enabled formulation have distributed bioweapon capability beyond the skillcraft of traditional state laboratories. Although specialized methods and equipment are required for bioagent manufacture, the relative ease of acquiring and using these means is such that more actors can gain access to such agents and can do so without the need for bespoke facilities.